Creatinine no greater than the institutional upper limits of normal
Total bilirubin within =< 1.5 normal institutional limits (patients with Gilberts syndrome with total bilirubin up to 2.5 mg/dL is allowed)
Obtained within 30 days of registration: Total bilirubin within normal institutional limits (may be elevated if direct bilirubin normal)
Bilirubin within normal institutional limits within 14 days prior to registration
Creatinine =< 2 x institutional upper limits of normal
Total bilirubin < 1.5 x upper limits of normal (ULN)
Total serum bilirubin within normal institutional limits
Total bilirubin < 1.5 x upper limits of normal (ULN)
RE-REGISTRATION ELIGIBILITY CRITERIA (STEP 2): Total bilirubin < 1.5 x upper limits of normal (ULN)
Total bilirubin within normal institutional limits
Creatinine within normal institutional limits OR
Total bilirubin =< 1.5 x upper limits of normal (ULN)
Cardiac function within institutional normal limits on echocardiogram
Total bilirubin < 1.5 x institutional upper limit of normal with direct bilirubin within normal limits except for participants with Gilberts disease
Bilirubin =< 2.0 x upper limits of normal (ULN)
Total bilirubin within institutional normal limits (or < 2.5 X the ULN for patients with Gilberts disease)
Total bilirubin within normal institutional limits
Total bilirubin within normal institutional limits
Total bilirubin within normal institutional limits
Within 14 days of registration: Bilirubin =< 1.5 x upper limits of normal (ULN)
Total bilirubin within normal institutional limits
Total bilirubin within =< 1.5 times the upper limit of normal (ULN) institutional limits
Total bilirubin within normal institutional limits
Creatinine within normal institutional limits OR
Total bilirubin within normal institutional limits
Total bilirubin within normal institutional limits
Serum bilirubin =< 1.5 x institutional upper limits of normal (ULN); must be obtained within 28 days prior to registration
Serum bilirubin =< 2.5 times ULN except for participants who are on atazanavir or indinavir, provided that the participants direct bilirubin is within normal institutional limits
Within 2 weeks prior to initiation of study treatment: Total bilirubin within normal institutional limits
Total bilirubin within normal institutional limits
Total bilirubin within normal institutional limits
Total bilirubin within normal institutional limits
Total bilirubin: within normal limits at each study site local laboratory
Total bilirubin within normal institutional limits
Total bilirubin within normal institutional limits
Creatinine within normal institutional limits
Total bilirubin =< 1.5 x normal institutional limits; this will not apply to patients with confirmed Gilberts syndrome (persistent or recurrent hyperbilirubinemia [predominantly unconjugated bilirubin] in the absence of evidence of hemolysis or hepatic pathology), who will be allowed in consultation with their physician
Total bilirubin within normal institutional limits
Bilirubin within institutional normal limits
